Tonya Cremin, DO | |
324 Elm St Ste 203a, Monroe, CT 06468-2282 | |
(203) 445-9060 | |
(203) 445-9093 |
Full Name | Tonya Cremin |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 324 Elm St Ste 203a, Monroe, Connecticut |
Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093890162 | NPI | - | NPPES |
001447532 | Medicaid | CT | |
044753 | Other | CT | MEDICAL LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 044753 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Tonya Cremin, DO 324 Elm St Ste 203a, Monroe, CT 06468-2282 Ph: (203) 445-9060 | Tonya Cremin, DO 324 Elm St Ste 203a, Monroe, CT 06468-2282 Ph: (203) 445-9060 |
News Archive
Researchers at Weill Cornell Medical College have uncovered a mechanism that guides the exquisite wiring of neural circuits in a developing brain - gaining unprecedented insight into the faulty circuits that may lead to brain disorders ranging from autism to mental retardation.
Exciting Australian biotech, Bionomics has announced that it has completed the acquisition of the French central nervous system (CNS) business, Neurofit.
Progenics Pharmaceuticals, Inc. today announced the initiation of a phase 2 clinical trial of subcutaneous methylnaltrexone in Japan by its collaborator, Ono Pharmaceutical Co., Ltd. The drug, designated ONO-3849 in Japan, is being evaluated for the treatment of opioid-induced constipation (OIC) in patients with advanced illness such as cancer.
Scientists working on a common antimicrobial compound with antimalarial activity have discovered a range of new therapeutic strategies to combat malaria.
› Verified 5 days ago